CXCL1 and metabolic dysfunction-associated steatotic liver disease: The unexpected decrease in the pro-inflammatory chemokines Cxcl1 and Ccl9 (by 4.4-fold and 10-fold, respectively) requires further investigation as it may represent an early compensatory response or a more complex modulation of the inflammatory process in the development of MASLD.